Jewell D, Caprilli R, Mortensen N, Nicholls RJ, Wright JP. Indication and timing of surgery for severe ulcerative colitis. Gastroenterol Intern 1991 ; 4 : 161-4.
Schumacher G, Kolberg B, Sandstedt B. A prospective study of first attacks of inflammatory bowel disease and infectious colitis : histologic course during the first year after presentation. Scand J Gastroenterol 1994 ; 29 : 318-32.
Evans JM, McMahon AD, Murray FE, McDevitt DG, MacDonald TM. Non-steroidal antiinflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 1997 ; 40 : 619-22
Notteghem B, Salomez JL, Gower-Rousseau C, Mari R, Lemahieu M, Nuttens MC et al. Que deviennent les colites aiguës inclassées? Résultats d'une étude de cohorte de 104 malades dans la région Nord-Pas-de-Calais. Gastroenterol Clin Biol 1993 ; 17 : 811-5.
Gast P, Belaiche J. Rectal endosonography in inflammatory bowel disease : differential diagnosis and prediction of remission. Endoscopy 1999 ; 31 : 158-67.
Belaiche J, Louis E, D'Haens G, Cabooter M, Naegels S, De Vos, et al. Acute lower gastrointestinal bleeding in Crohn's disease : characteristics of a unique series of 34 patients. Am J Gastroenterol 1999 ; 94 : 2177-81.
Present DH, Wolfson D, Gelernt IM, Rubbin PH, Bauer J Chapman ML. Medical decompression or toxic megacolon by «rolling»: a new technique of decompression with favorable long ferme follow-up. J Clin Gastroenterol 1988 ; 10 : 485-90
Truelove SC, Witts LJ. Cortisone in ulcerative colitis : final report on a therapeutic trial. Br Med J 1955 ; 2 : 1041-8.
Marion JF, Present DH. The modern medical management of acute, severe ulcerative colitis Eur J Gastroenterol Hepatol 1997 ; 9 : 831-5
Walmsley RS, Ayres RCS, Pounder RE, Allan RN A simple clinical colitis activity index. Gut 1998 ; 43 : 29-32.
Prantera C, Lorenzetti R, Cerro P, Davoli M, Brancato G, Fanucci A. The plain abdominal film accurately estimates extent of active ulcerative colitis. J Clin Gastroenterol 1991 ; 13 : 231-4.
Present D Management of acute severe colitis. In : Allan RN, Rhodes JM, Hanauer SB, Keighley MRB, Alexander-Williams J, Fazio VW, eds. Inflammatory bowel diseases. New York : Churchill Livingstone, 1997 : 565-70.
Alemayehu G, Jarnerot G. Colonoscopy during an attack of severe ulcerative colitis is a safe procedure and of great value in clinical decision making. Am J Gastroenterol 1991 ; 86 : 187-90.
Carbonnel F, Lavergne A, Lemann M, Bitoun A, Valleur P, Hautefeuille P, et al. Colonoscopy of acute colitis : a safe and reliable tool for the assessment of severity. Dig Dis Sci 1994 ; 39 : 1550-7
Guédon C, Lerebours E. Nutrition artificielle et maladie de Crohn. Gastroenterol Clin Biol 1993 ; 17 : 352-9.
Sitzman JV, Converse RL, Bayless TM. Favorable response to parenteral nutrition and medical therapy in Crohn's colitis. Gastroenterology 1990 ; 99 : 1647-52.
Kornbluth AA, Marion JF, Salomon P, Janowitz HD. How effective is current medical therapy for severe ulcerative and Crohn's colitis? An analytic review of selected trials. J Clin Gastroenterol 1995 ; 20 : 280-4.
Meyers S, Sachar DB, Goldberg JD, Janowitz HO. Corticotrophin versus hydrocortisone in the intravenous treatment of ulcerative colitis. Gastroenterology 1983 ; 85 : 351-7.
Chapman RW, Selby WS, Jewell DP. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut 1986 ; 27 : 1210-2.
Dicknson RJ, O'Conner HJ, Pinder I, Hamilton I, Johnston D, Axon AT. Double-blind controlled trial of oral vancomycin as adjunction therapy in acute exarcebation of ulcerative colitis Gut 1985 ; 26 : 1380-4
Mantzaris GJ, Hatzis A, Kontogiannis P, Triadaphyllou G. Intravenous tobramycine and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis. Am J Gastroenterol 1994 ; 89 : 43-6.
George J, Present DH, Pou R, Bodian C, Rubin PH. The long-term outcome of ulcerative colitis treated with 6-mercaptopurine. Am J Gastroenterol 1996 ; 91 : 1711-4.
Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn's disease : a meta-analysis. Ann Inter Med 1995 ; 122 : 132-42
Lichtiger S, Present DH, Kombluth A, Gelernt I, Bauer G, Galler G, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994 ; 330 : 1841-5.
Sandborn WJ A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis 1995 ; 1 : 48-63.
Carbonnel F, Boruchowicz A, Duclos B, Soulé JC, Lerebours E, Lemann M, et al. Intravenous cyclosporine in attacks of ulcerative colitis Short-term and long-term responses. Dig Dis Sci 1996 ; 41 : 2471-6.
Van Gossum A, Schmit A, Adler M, Chioccioli C, Fiasse R, Louwagie P, et al. Short- and long-term efficacy of cyclosporin administration in patients with acute severe ulcerative colitis. Acta Gastroenterol Bel 1997 ; 60 : 197-200.
Stack WA, Long RG, Hawkey CJ. Short-and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis. Aliment Pharmacol Ther 1998 ; 12 : 973-8.
Hyde GM, Thillainayagam AV, Jewell DP. Intravenous cyclosporin as rescue therapy in severe ulcerative colitis : time for a reappraisal? Eur J Gastroenterol Hepatol 1998 ; 10 : 411-3.
Fernandez-Banares F, Bertran X, Esteve-Comas M, Cabre E, Menacho M, Humbert P, et al. Azathioprine is useful in maintenaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis. Am J Gastroenterol 1996 ; 91 : 2498-9
Bouhnik Y, Rambaud JC. Utilisation des immunosuppresseurs au cours des MICI : données récentes. In : Lemann M, Modigliani R, eds. Maladies inflammatoires de l'intestin. Paris : Doin, 1998 : 173-90.
Jewell DP. The management of severe ulcerative colitis. In : Mignon M, Colombel JF, eds. Recent advances in the pathophysiology and management of inflammatory bowel diseases and digestive endocrine fumors John Libbey Eurotext, Paris, 1999 : 128-35
Hyde GM, Warren BF, Jewell DP. Histological changes following intravenous cyclosporin in the treatment of refractory severe ulcerative colitis may mime dysplasia. Gastroenterology 1998 ; 114 : G40995.
Actis GC, Ottobrelli A, Pera A, Barletti C, Ponti V, Pinna-Pintor M, et al. Continuously infused cyclosporine at low doses is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids. J Clin Gastroenterol 1993 ; 17 : 10-3
D'Haens G, Lemmens L, Hiele M, Vandeputte L, Nevens F, Peeters M, et al. Intravenous cyclosporine A (CyA) monotherapy versus intravenous methylprednisolone (MP) monotherapy in severe ulcerative colitis : a double blind controlled trial. Gastroenterology 1998 ; 114 : G3948).
Svanoni F, Bonassi U, Bagnolo F, Caporuscio S. Effectiveness of cyclosporine A in the treatment of active refractory ulcerative colitis Gastroenterology 1998 ; 114 : G4484.
Actis GC, Aimo G, Moscato D, Rizzetto M, Pagni R. Efficacy and efficiency of oral microemulsion cydosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis : an open-label retrospective trial. Inflam Bowel Dis 1998 ; 4 : 276-9
Santos JV, Baudet JA, Casellas FJ, Guarner LA, Vilaseca JM, Malagelada JR. Intravenous cyclosporine for steroid-refractory attacks of Crohn's disease. Short- and long-term results. J Clin Gastroenterol 1995 ; 20 : 207-10
Lémann M, de La Valussière F, Bouhnik Y, Allez M, Touze Y Bonnet J, et al. Intravenous cyclosporine for refractory attacks of Crohn's disease : a long term follow-up of patients Gastroenterology 1998 ; 113 : G4178
Evans RC, Clarcke L, Heath P, Stephens S, Morris AI, Rhodes JM. Treatment of corticosteroid resistant ulcerative colitis with heparin : a report of 16 cases. Aliment Pharmacol Ther 1997 ; 11 : 1037-40
Korzenik JR, Robert ME, Bitton A, Robinson M, Scherl EJ, Fisher RL, et al. A multi-center randomized, controlled trial of heparin for the treatment of ulcerative colitis. Gastroenterology 1999 ; 116 : G3264.
Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF. Steroid-unresponsive acute attacks of inflammatory bowel disease : immunomodulation by tacrolimus (FK506). Am J Gastroenterol 1998 ; 93 : 1860-6.
Smithson JE, Grool TA, Van Deventer SJH, Jewell DP. Controlled clinical trial of lexipafant in addition to corticosteroids in severe ulcerative colitis. Gastroenterology 1997 ; 112 : A1094.
Lémann M, Modigliani R. Traitement des MICI : vue d'ensemble In : Lémann M, Modigliani R, eds. Maladies inflammatoires de l'intestin. Paris : Doin, 1998 : 225-71
Meyers S, Lerer PK, Feuer EJ, Johnson JW, Janowitz HD. Predicting the outcome of corticoid therapy for acute ulcerative colitis : results of a prospective randomized double-blind trial. J Clin Gastroenterol 1987 ; 9 : 50-4.
Travis SPL, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MGW, et al. Predicting outcome in severe ulcerative colitis Gut 1996 ; 38 : 905-10.
Lindgren SC, Flood LM, Kilander AF, Lofberg R, Persson TB, Sjodahl RI. Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol 1998 ; 10 : 831-5.
Sandborn WJ, Landers O, Tremaine WJ, Targant SR. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis : results of a pilot study. Mayo Clin Proc 1996 ; 71 : 431-6
Hearing SD, Norman M, Probert CSJ, Haslam N, Dayan CM. Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating perpheral blood lymphocytes Gut 1999 ; 45 : 382-8.
Almer S, Bodemar G, Franzen L, lindstrom E, Nystrom P, Strom M. Use of air enema radiography to assess depth of ulceration during acute attacks or ulcerative colitis Lancet 1996 ; 347 : 1731-5
